SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-213186
Filing Date
2022-08-05
Accepted
2022-08-05 08:26:38
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d348445d10q.htm   iXBRL 10-Q 1210697
2 EX-31.1 d348445dex311.htm EX-31.1 10139
3 EX-31.2 d348445dex312.htm EX-31.2 10212
4 EX-32 d348445dex32.htm EX-32 4500
10 GRAPHIC g348445dsp1.jpg GRAPHIC 19706
  Complete submission text file 0001193125-22-213186.txt   6059751

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vivo-20220630.xsd EX-101.SCH 54107
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20220630_cal.xml EX-101.CAL 47962
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20220630_def.xml EX-101.DEF 252208
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20220630_lab.xml EX-101.LAB 381479
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20220630_pre.xml EX-101.PRE 343361
70 EXTRACTED XBRL INSTANCE DOCUMENT d348445d10q_htm.xml XML 1012935
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 221138713
SIC: 2835 In Vitro & In Vivo Diagnostic Substances